Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × ivosidenib × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 8 Glioma 3 Wilms Tumor 2 Sarcoma, Ewing 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Ependymoma 2 Cholangiocarcinoma 2 Xanthogranuloma, Juvenile 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Leukemia 1 IDH1-Mutated Malignancies 1 Histiocytic Sarcoma 1 Central Nervous System Neoplasms 1

Interventions

Gemcitabine 13 Cisplatin 12 durvalumab 9 Leucovorin 6 Fluorouracil 5 pembrolizumab 4 Oxaliplatin 4 Nivolumab 4 lenvatinib 3 irinotecan sucrosofate 3 Liquid Biopsy 3 S 1 (combination) 2 Itraconazole 2 Irinotecan 2 Injections 2 Folfox protocol 2 Carboplatin 2 Capecitabine 2 Bevacizumab 2 zanidatamab 1 trifluridine tipiracil drug combination 1 trastuzumab deruxtecan 1 tislelizumab 1 pertuzumab 1 mitazalimab 1 gemcitabine-oxaliplatin regimen 1 devimistat 1 brigimadlin 1 Tegafur 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡